Inverse Head&Shoulders It's clearly to see a potential inverse head and shoulders forming in NYSE:LLY which can lead us back to $900 area.
Key facts today
125.249 ARS
1.54 T ARS
10.05 T ARS
About Eli Lilly and Company
Sector
CEO
David A. Ricks
Headquarters
Indianapolis
Website
Founded
1876
ISIN
ARDEUT111192
FIGI
BBG000HFTQS8
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Why Buy LLY?A textbook spike trade... that's why!
Every morning the stock market open gives us opening volatility spikes on the first 30 minute bar. Most are noise but when that rare one comes along that fits my rules AND has multiple matching confluences... it's time to "Strike at the Spike!"
This setup has
Eli Lilly: Is the Uptrend Fading?Eli Lilly has been one of the best-performing large-cap stocks in recent years. But now it may be showing signs of stalling.
The first pattern on today’s chart is the bearish price gap on October 30 after earnings and revenue missed estimates. LLY has remained below the gap since, which may suggest
Eli Lilly is facing problems after the earnings presentation🔴 Eli Lilly is facing problems after the earnings presentation
NYSE:LLY has broken an especially important support and is now in free fall. Avoid buying it now.
The break also activates the bearish double top and that means that the $550 is the target of the pattern. If you look close to the
LLY 1H Swing Long Aggressive Trend TradeAggressive Trend Trade
- short impulse
+ volumed TE / T1
+ support level
+ biggest volume Sp
+ weak test
+ first bullish bar close entry
Calculated affordable stop limit
1 to 2 R/R take profit
Daily Context
"+ long impulse
+ 1/2 correction
- expanding T2
+ support level
+ volumed manipulation"
Mo
Can Pharma Innovation Rewrite Healthcare's Future?In the rapidly evolving landscape of medical technology, Eli Lilly emerges as a beacon of transformative potential, challenging conventional boundaries of pharmaceutical innovation. With a strategic masterstroke, the company has positioned itself at the forefront of medical breakthroughs, particular
Steady rebound may fuel LLY to new high NYSE:LLY Has rebounded after forming a bear trap below the key support of 743.12. Subsequent minor gap up and steady flow of upside has confirmed the long-term uptrend for LLY. However, I would look at 880.10 as my first target.
$LLY Long-Term BuyHealthcare could possibly be the next rotation coming out of this tech bull run. Using the Trade Jeanie (Jeanius Screener/Indicator), I was able to see the current technical buy signals happening on NYSE:LLY :
Inside a HTF fair value gap (3M timeframe)
Took out an untested low (liquidity)
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
